References
1. Rodés-Cabau J, Taramasso M, O’Gara PT. Diagnosis and treatment of tricuspid valve disease: current and future perspectives. Lancet . 2016;388(10058):2431-2442. doi:10.1016/S0140-6736(16)00740-6
2. Nath J, Foster E, Heidenreich PA. Impact of Tricuspid Regurgitation on Long-Term Survival. J Am Coll Cardiol . 2004;43(3):405-409. doi:10.1016/j.jacc.2003.09.036
3. Topilsky Y, Nkomo VT, Vatury O, et al. Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging . 2014;7(12):1185-1194. doi:10.1016/j.jcmg.2014.07.018
4. Alqahtani F, Berzingi CO, Aljohani S, Hijazi M, Al-Hallak A, Alkhouli M. Contemporary Trends in the Use and Outcomes of Surgical Treatment of Tricuspid Regurgitation. J Am Heart Assoc . 2017;6(12). doi:10.1161/JAHA.117.007597
5. Zack CJ, Fender EA, Chandrashekar P, et al. National Trends and Outcomes in Isolated Tricuspid Valve Surgery. J Am Coll Cardiol . 2017;70(24):2953-2960. doi:10.1016/j.jacc.2017.10.039
6. McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: Durability and risk factors for failure. J Thorac Cardiovasc Surg . 2004;127(3):674-685. doi:10.1016/j.jtcvs.2003.11.019
7. Kwak J, Kim Y, Kim M, et al. Development of tricuspid regurgitation late after left-sided valve surgery: a single-center experience with long-term echocardiographic examinations. Am Heart J . 2008;4(155):732-737.
8. Baumgartner H, Falk V, Bax J, et al. 2017 ESC / EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology ( ESC ) and the European. Eur Heart J . 2017;38:2739-2791. doi:10.1093/eurheartj/ehx391
9. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation . 2021;143(5):e72-e227. doi:10.1161/CIR.0000000000000923
10. Lee JW, Song JM, Park JP, Lee JW, Kang DH, Song JK. Long-term prognosis of isolated significant tricuspid regurgitation. Circ J . 2010;74(2):375-380. doi:10.1253/circj.CJ-09-0679
11. Fukuda S, Gillinov AM, McCarthy PM, et al. Determinants of recurrent or residual functional tricuspid regurgitation after tricuspid annuloplasty. Circulation . 2006;114(SUPPL. 1):582-587. doi:10.1161/CIRCULATIONAHA.105.001305
12. Vassileva CM, Shabosky J, Boley T, Markwell S, Hazelrigg S. Tricuspid valve surgery: The past 10 years from the Nationwide Inpatient Sample (NIS) database. J Thorac Cardiovasc Surg . 2012;143(5):1043-1049. doi:10.1016/j.jtcvs.2011.07.004
13. Kilic A, Saha-Chaudhuri P, Rankin JS, Conte J V. Trends and outcomes of tricuspid valve surgery in north america: An analysis of more than 50,000 patients from the society of thoracic surgeons database.Ann Thorac Surg . 2013;96(5):1546-1552. doi:10.1016/j.athoracsur.2013.06.031
14. Zhu TY, Wang JG, Meng X. Does concomitant tricuspid annuloplasty increase perioperative mortality and morbidity when correcting left-sided valve disease? Interact Cardiovasc Thorac Surg . 2015;20(1):114-119. doi:10.1093/icvts/ivu326
15. Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: An executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging . 2013;14(7):611-644. doi:10.1093/ehjci/jet105
16. Lancellotti P, Moura L, Pierard L, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr . 2010;4(11):307-332.
17. Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr . 2017;30(4):303-371. doi:10.1016/j.echo.2017.01.007
18. Pfannmüller B, Davierwala P, Misfeld M, Borger MA, Garbade J, Mohr FW. Postoperative outcome of isolated tricuspid valve operation using arrested-heart or beating-heart technique. Ann Thorac Surg . 2012;94(4):1218-1222. doi:10.1016/j.athoracsur.2012.05.020
19. Pfannmüller B, Misfeld M, Borger MA, et al. Isolated reoperative minimally invasive tricuspid valve operations. Ann Thorac Surg . 2012;94(6):2005-2010. doi:10.1016/j.athoracsur.2012.06.064
20. Topilsky Y, Khanna AD, Oh JK, et al. Preoperative factors associated with adverse outcome after tricuspid valve replacement.Circulation . 2011;123(18):1929-1939. doi:10.1161/CIRCULATIONAHA.110.991018
21. Shiran A, Sagie A. Tricuspid Regurgitation in Mitral Valve Disease. Incidence, Prognostic Implications, Mechanism, and Management. J Am Coll Cardiol . 2009;53(5):401-408. doi:10.1016/j.jacc.2008.09.048
22. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet . 2006;368(9540):1005-1011. doi:10.1016/S0140-6736(06)69208-8
23. Kamath PS, Kim WR. The model for end‐stage liver disease (MELD).Hepatology . 2007;45:797-805.
24. Anderson M, Morris L, Tang D, Meraj P, Kapur NK, O’Neill WW. Outcomes of patients with right ventricular failure requiring short-term hemodynamic support with the Impella RP device. J Hear Lung Transplant . 2018;37(12):1448-1458.
25. Hall S, Uriel N, Carey S, et al. Use of a percutaneous temporary circulatory support device as a bridge to decision during acute decompensation of advanced heart failure. J Hear Lung Transplant . 2018;37(1):100-106.
26. Asmarats L, Puri R, Latib A, Navia JL, Rodés-Cabau J. Transcatheter Tricuspid Valve Interventions: Landscape, Challenges, and Future Directions. J Am Coll Cardiol . 2018;71(25):2935-2956. doi:10.1016/j.jacc.2018.04.031
27. Buzzatti N, De Bonis M, Moat N. Anatomy of the Tricuspid Valve, Pathophysiology of Functional Tricuspid Regurgitation, and Implications for Percutaneous Therapies. Interv Cardiol Clin . 2018;7(1):1-11. doi:10.1016/j.iccl.2017.08.005
28. De Bonis M, Taramasso M, Lapenna E, Alfieri O. Management of Tricuspid Regurgitation. F1000 Prime Reports . 2014;6(58):1-6. doi:10.12703/P6-58